AGLE – Aeglea BioTherapeutics, Inc.
Float Short %
3.96
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
8.43
EPS Last/This Y
19.42
EPS This/Next Y
0.33
Price
12.01
Target Price
17.5
Analyst Recom
2
Performance Q
-9.58
Relative Volume
0.96
Beta
2.46
Ticker: AGLE
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-11-17 | AGLE | 12.01 | N/A | N/A | 0 |
| 2025-11-18 | AGLE | 12.01 | N/A | N/A | 0 |
| 2025-11-19 | AGLE | 12.01 | N/A | N/A | 0 |
| 2025-11-20 | AGLE | 12.01 | N/A | N/A | 0 |
| 2025-11-21 | AGLE | 12.01 | N/A | N/A | 0 |
| 2025-11-24 | AGLE | 12.01 | N/A | N/A | 0 |
| 2025-11-25 | AGLE | 12.01 | N/A | N/A | 0 |
| 2025-11-26 | AGLE | 12.01 | N/A | N/A | 0 |
| 2025-12-01 | AGLE | 12.01 | N/A | N/A | 0 |
| 2025-12-02 | AGLE | 12.01 | N/A | N/A | 0 |
| 2025-12-03 | AGLE | 12.01 | N/A | N/A | 0 |
| 2025-12-04 | AGLE | 12.01 | N/A | N/A | 0 |
| 2025-12-05 | AGLE | 12.01 | N/A | N/A | 0 |
| 2025-12-08 | AGLE | 12.01 | N/A | N/A | 0 |
| 2025-12-09 | AGLE | 12.01 | N/A | N/A | 0 |
| 2025-12-10 | AGLE | 12.01 | N/A | N/A | 0 |
| 2025-12-11 | AGLE | 12.01 | N/A | N/A | 0 |
| 2025-12-12 | AGLE | 12.01 | N/A | N/A | 0 |
| 2025-12-15 | AGLE | 12.01 | N/A | N/A | 0 |
| 2025-12-16 | AGLE | 12.01 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
No data found
No data found
Last Quarter Act. EPS
-9.34
Avg. EPS Est. Current Quarter
-0.91
Avg. EPS Est. Next Quarter
-0.58
Insider Transactions
Institutional Transactions
-60.95
Beta
2.46
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
38
Growth Score
35
Sentiment Score
60
Actual DrawDown %
95.8
Max Drawdown 5-Year %
-99
Target Price
17.5
P/E
Forward P/E
PEG
P/S
46.32
P/B
P/Free Cash Flow
EPS
-78.22
Average EPS Est. Cur. Y
-5.33
EPS Next Y. (Est.)
-1.84
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-27934.72
Relative Volume
0.96
Return on Equity vs Sector %
96.2
Return on Equity vs Industry %
77.2
EPS 1 7Days Diff
EPS 1 30Days Diff
1.72
EBIT Estimation
stock quote shares AGLE – Aeglea BioTherapeutics, Inc. Stock Price stock today
news today AGLE – Aeglea BioTherapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch AGLE – Aeglea BioTherapeutics, Inc. yahoo finance google finance
stock history AGLE – Aeglea BioTherapeutics, Inc. invest stock market
stock prices AGLE premarket after hours
ticker AGLE fair value insiders trading